Clinical Research Directory
Browse clinical research sites, groups, and studies.
68Ga-DOTATATE Neuroblastoma Imaging Pilot
Sponsor: Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Summary
Neuroblastoma is the most frequent extracranial childhood tumor, with an annual incidence of approximately 10.2 per million children. Staging of the disease can be done by different imaging strategies (CT, MRI, scintigraphy and PET/CT). Discrepancies may be observed among these different strategies resulting in different treatment strategies. The goal of this study is to assess the feasibility and safety of 68Ga-DOTATATE and to compare it to 123I-MIBG when investigating neuroblastoma.
Official title: Pilot Study of 68Ga-DOTATATE PET/CT and 123I-MIBG Scintigraphy Imaging of Neuroblastoma
Key Details
Gender
All
Age Range
Any - 21 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2021-12-06
Completion Date
2027-09-30
Last Updated
2024-08-23
Healthy Volunteers
No
Conditions
Interventions
Radiopharmaceutical 68Ga-DOTATATE
Injection of 68Ga-DOTATATE followed by PET/CT acquisition
Locations (3)
McGill University Health Center - Children's hospital
Montreal, Quebec, Canada
CHU Ste-Justine
Montreal, Quebec, Canada
CIUSSS de l'Estrie-CHUS Hospital
Sherbrooke, Quebec, Canada